My research focuses on cancer and metabolic disease drug discovery, integrating natural and synthetic complexes with nano- and targeted delivery strategies. Through international collaborations, I’ve advanced the development of polymeric nanoparticles, thin films, and carbon dots as targeted drug carriers, and uncovered the therapeutic promise of marine and terrestrial bioactives that trigger apoptosis via complex molecular pathways. This work bridges chemistry, nanotechnology, and biology, driving innovation toward more effective and precise therapies.